RELATED CONTENT
NEWS
- NeoStem raises $16.5M as it continues to shift its focus to cell therapy
- Conditional European approval for Fampyra for MS walking disability
- UK govt offers "step change" in support for regenerative medicine
- Messy compromise on combo SPCs could thicken thickets and increase litigation

